SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-14-009685
Filing Date
2014-02-13
Accepted
2014-02-13 14:01:02
Documents
1
Group Members
ADVENT MANAGEMENT III L.P.ADVENT MANAGEMENT III LTDADVENT MANAGEMENT IV L.P.ADVENT MANAGEMENT IV LTDADVENT PRIVATE EQUITY FUND III A L.P.ADVENT PRIVATE EQUITY FUND III AFFILIATES L.P.ADVENT PRIVATE EQUITY FUND III B L.P.ADVENT PRIVATE EQUITY FUND III C L.

Document Format Files

Seq Description Document Type Size
1 SC 13G a14-5701_1sc13g.htm SC 13G 346633
  Complete submission text file 0001104659-14-009685.txt   348479
Mailing Address 25 BUCKINGHAM GATE LONDON A1 00000
Business Address
ADVENT VENTURE PARTNERS LLP (Filed by) CIK: 0001285114 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87858 | Film No.: 14604946
SIC: 2834 Pharmaceutical Preparations